Endoscopy
DOI: 10.1055/a-2595-5381
Original article

Trends over time and interhospital variation in the primary treatment approach for T1 colon carcinomas in the Netherlands

1   Department of Gastroenterology and Hepatology, Isala, Zwolle, Netherlands (Ringgold ID: RIN8772)
,
Felice N. van Erning
2   Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Utrecht, Netherlands
3   Department of Surgery, Catharina Hospital, Eindhoven, Netherlands (Ringgold ID: RIN3168)
,
Wouter H de Vos tot Nederveen Cappel
1   Department of Gastroenterology and Hepatology, Isala, Zwolle, Netherlands (Ringgold ID: RIN8772)
,
Frank P. Vleggaar
4   Department of Gastroenterology and Hepatology, University Medical Centre Utrecht, Utrecht, Netherlands (Ringgold ID: RIN8124)
,
H L van Westreenen
5   Department of Surgery, Isala, Zwolle, Netherlands (Ringgold ID: RIN8772)
,
Leon MG Moons
4   Department of Gastroenterology and Hepatology, University Medical Centre Utrecht, Utrecht, Netherlands (Ringgold ID: RIN8124)
› Author Affiliations


Abstract

Background

This study evaluated the use of local resection as initial treatment vs. primary surgery for T1 colon carcinoma in the Netherlands over time, hospital variations, and whether changes in treatment approaches impacted 5-year relative and overall survival.

Methods

This nationwide cohort study included patients diagnosed with pT1 colon adenocarcinoma in 2015–2022, identified from the Netherlands Cancer Registry. Multilevel, multivariable logistic regression models estimated the probability of undergoing local resection per hospital, adjusted for case-mix variables. Hospitals were categorized into low, average, or high attitude toward local resection. Relative and overall survival were calculated using multivariable regression analysis.

Results

9650 patients from 73 hospitals were included, with 3999 (41.4%) receiving primary surgery and 5651 (58.6%) undergoing local resection first. From 2015 to 2022, the proportion of primary surgery decreased from 53.2% to 29.7%. The adjusted relative risk for local resection varied across hospitals (0.46–1.29). No significant differences in 5-year relative or overall survival were found between high vs. low attitude centers (relative survival 99.0% vs. 97.7%, relative excess risk [RER] 0.97, 95%CI 0.51–1.84; overall survival 87.9% vs. 86.4%, adjusted hazard ratio [aHR] 0.95, 95%CI 0.81–1.11), nor between patients treated after vs. before 2018 (relative survival 98.7% vs. 98.7%, RER 0.82, 95%CI 0.46–1.46; overall survival 86.7% vs. 88.0%, aHR 0.98, 95%CI 0.85–1.13).

Conclusions

While interhospital variation existed, local resection of T1 colon carcinoma was increasingly preferred in the Netherlands, leading to a reduction in surgery without a change in relative or overall survival.

Supplementary Material



Publication History

Received: 01 December 2024

Accepted after revision: 27 April 2025

Accepted Manuscript online:
27 April 2025

Article published online:
13 June 2025

© 2025. Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany

 
  • References

  • 1 Vermeer NCA, Backes Y, Snijders HS. et al. National cohort study on postoperative risks after surgery for submucosal invasive colorectal cancer. BJS Open 2019; 3: 210-217
  • 2 Backes Y, Elias SG, Groen JN. et al. Histologic factors associated with need for surgery in patients with pedunculated T1 colorectal carcinomas. Gastroenterology 2018; 154: 1647-1659
  • 3 Bosch SL, Teerenstra S, de Wilt. et al. Predicting lymph node metastasis in pT1 colorectal cancer: a systematic review of risk factors providing rationale for therapy decisions. Endoscopy 2013; 45: 827-834
  • 4 Ueno H, Mochizuki H, Hashiguchi Y. et al. Risk factors for an adverse outcome in early invasive colorectal carcinoma. Gastroenterology 2004; 127: 385-394
  • 5 Fuccio L, Hassan C, Ponchon T. et al. Clinical outcomes after endoscopic submucosal dissection for colorectal neoplasia: a systematic review and meta-analysis. Gastrointest Endosc 2017; 86: 74-86.e17
  • 6 Kuellmer A, Mueller J, Caca K. et al. Endoscopic full-thickness resection for early colorectal cancer. Gastrointest Endosc 2019; 89: 1180-1189.e1
  • 7 Hanevelt J, Moons LMG, Hentzen JEKR. et al. Colonoscopy-assisted laparoscopic wedge resection for the treatment of suspected T1 colon cancer. Ann Surg Oncol 2023; 30: 2058-2065
  • 8 Zwager LW, Bastiaansen BAJ, Montazeri NSM. et al. Deep submucosal invasion is not an independent risk factor for lymph node metastasis in T1 colorectal cancer: a meta-analysis. Gastroenterology 2022; 163: 174-189
  • 9 Federatie Medisch Specialisten. Richtlijn – Colorectaal carcinoom (CRC). 2023 https://richtlijnendatabase.nl/richtlijn/colorectaal_carcinoom_crc/startpagina_-_colorectaal_carcinoom.html
  • 10 Argilés G, Tabernero J, Labianca R. et al. Localised colon cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 2020; 31: 1291-1305
  • 11 Ebbehøj AL, Jørgensen LN, Krarup PM. et al. Histopathological risk factors for lymph node metastases in T1 colorectal cancer: meta-analysis. Br J Surg 2021; 108: 769-776
  • 12 Dang H, de Vos Tot Nederveen Cappel WH, van der Zwaan SMS. et al. Quality of life and fear of cancer recurrence in T1 colorectal cancer patients treated with endoscopic or surgical tumor resection. Gastrointest Endosc 2019; 89: 533-544
  • 13 Zwager LW, Mueller J, Stritzke B. et al. Adverse events of endoscopic full-thickness resection: results from the German and Dutch nationwide colorectal FTRD registry. Gastrointest Endosc 2023; 97: 780-789.e4
  • 14 Hanevelt J, Leicher LW, Moons LMG. et al. Colonoscopic-assisted laparoscopic wedge resection versus segmental colon resection for benign colonic polyps: a comparative cost analysis. Colorectal Dis 2023; 25: 2147-2154
  • 15 Brink AG, Hanevelt J, Leicher LW. et al. Colonoscopy-assisted laparoscopic wedge resection for colonic lesions and its impact on quality of life: results from the LIMERIC study. Dis Colon Rectum 2025; 68: 242-251
  • 16 Overwater A, Kessels K, Elias SG. et al. Endoscopic resection of high-risk T1 colorectal carcinoma prior to surgical resection has no adverse effect on long-term outcomes. Gut 2018; 67: 284-290
  • 17 Nian J, Tao L, Zhou W. Prior endoscopic resection does not affect the outcome of secondary surgery for T1 colorectal cancer, a systematic review and meta-analysis. Int J Colorectal Dis 2022; 37: 273-281
  • 18 Oh EH, Kim N, Hwang SW. et al. Comparison of long-term recurrence-free survival between primary surgery and endoscopic resection followed by secondary surgery in T1 colorectal cancer. Gastrointest Endosc 2021; 94: 394-404
  • 19 Yeh J, Tseng C, Huang R. et al. Long-term outcomes of primary endoscopic resection vs surgery for T1 colorectal cancer: a systematic review and meta-analysis. Clin Gastroenterol Hepatol 2020; 18: 2813-2823.e5
  • 20 Tamaru Y, Kuwai T, Kajiwara Y. et al. Long-term outcomes of additional surgery after endoscopic resection versus primary surgery for T1 colorectal cancer. Am J Gastroenterol 2024; 119: 2418-2425
  • 21 Beldhuis IE, Marapin RS, Jiang YY. et al. Cognitive biases, environmental, patient and personal factors associated with critical care decision making: a scoping review. J Crit Care 2021; 64: 144-153
  • 22 Luijten JCHBM, Vissers PAJ, Geerts J. et al. Hospital practice variation in the proportion of patients with esophagogastric cancer discussed during an expert multidisciplinary team meeting. Eur J Surg Oncol 2023; 49: 106880
  • 23 Zwager LW, Bastiaansen BAJ, van der Spek BW. et al. Endoscopic full-thickness resection of T1 colorectal cancers: a retrospective analysis from a multicenter Dutch eFTR registry. Endoscopy 2022; 54: 475-485
  • 24 Nilsson E, Wetterholm E, Syk I. et al. Risk of recurrence in high-risk T1 colon cancer following endoscopic and surgical resection: registry-based cohort study. BJS Open 2024; 8: zrae053
  • 25 Backes Y, de Vos Tot Nederveen Cappel WH, van Bergeijk J. et al. Risk for incomplete resection after macroscopic radical endoscopic resection of T1 colorectal cancer: a multicenter cohort study. Am J Gastroenterol 2017; 112: 785-796
  • 26 Corre F, Albouys J, Tran V. et al. Impact of surgery after endoscopically resected high-risk T1 colorectal cancer: results of an emulated target trial. Gastrointest Endosc 2024; 99: 408-416.e2
  • 27 Kearney DE, Cauley CE, Aiello A. et al. Increasing incidence of left-sided colorectal cancer in the young: age is not the only factor. J Gastrointest Surg 2020; 24: 2416-2422
  • 28 Lu P, Fields AC, Vise AS. et al. Anatomic distribution of colorectal adenocarcinoma in young patients. Dis Colon Rectum 2019; 62: 920-924
  • 29 Vleugels JLA, Koens L, Dijkgraaf MGW. et al. Suboptimal endoscopic cancer recognition in colorectal lesions in a national bowel screening programme. Gut 2020; 69: 977-980
  • 30 Koyama Y, Yamada M, Makiguchi ME. et al. New scoring system to distinguish deep invasive submucosal and muscularis propria colorectal cancer during colonoscopy: a development and global multicenter external validation study (e-T2 Score). Gastrointest Endosc 2022; 96: 321-329.e2
  • 31 Luo X, Wang J, Han Z. et al. Artificial intelligence-enhanced white-light colonoscopy with attention guidance predicts colorectal cancer invasion depth. Gastrointest Endosc 2021; 94: 627-638.e1